Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of DermatologyContinue reading
Category Archives: AZBio News
TGen-led study discovers genetic cause of rare type of ovarian cancer
Scientific breakthrough could lead to new cancer treatments; study inspired by memory of 22-year-old patientContinue reading
FDA Approves Xolair(R) (omalizumab) for People with Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives
Xolair is the First Biologic Medicine Approved for CIU, a Burdensome Skin Condition that Can Cause Hives and Severe Itch and May Last Many Years. Nearly 50 Percent of Patients Have Inadequate Response to H1-antihistamines, Previously the Only Approved Therapy for CIU3. Approximately 1.5 Million People in U.S. have CIU.Continue reading
Opportunity Alert: VisionGate CLIA Lab Director
VisionGate is dedicated to saving lives through early cancer detection and prevention. The Cell-CT™ is a revolutionary automated 3D cell imaging platform that generates high-resolution 3D biosignatures from intact cells. They are currently recruiting for a CLIA Lab Director.Continue reading
UA Med Students in Phoenix Learn Next Destination at Match Day
Class of 37 from Downtown Phoenix Campus Will Be Fourth to GraduateContinue reading
TGen recognized as ‘2014 Economic Driver’ by Greater Phoenix Chamber of Commerce
GPCC Impact Awards recognize ability, tenacity and sense of communityContinue reading
Susavion Biosciences, Inc. Selected to Present at Cavendish Global Health Impact Forum
Cerebral Palsy and the Potential of Cord Blood Stem Cells
Clinical trials evaluating newborn stem cells as a treatment for pediatric patients with cerebral palsy may improve the availability of future therapeutic optionsContinue reading
Sir Richard Branson Takes The Stage at BIO 2014
Sir Richard Branson to Participate in Keynote Lunch Interview at the 2014 BIO International Convention in San Diego.
Keynote luncheon to take place Tuesday, June 24Continue reading
TGen study identifies gene fusion as likely cause of rare type of thyroid cancer
Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading